Circulation. 2006;113:1888-1904
doi: 10.1161/CIRCULATIONAHA.105.563213
doi: 10.1161/CIRCULATIONAHA.105.563213
(Circulation. 2006;113:1888-1904.)
© 2006 American Heart Association, Inc.
Basic Science for Clinicians |
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
Molecular and Pathophysiological Mechanisms
From the Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Md (J.K., M.J.Q.); Department of Pharmacology and Human Physiology, Section of Pharmacology, University of Bari Medical School, Bari, Italy (M.M.); and the Division of Cardiology, Gil Heart Center, Gachon Medical School, Incheon, Korea (K.K.K.).
Correspondence to Michael J. Quon, MD, PhD, Chief, Diabetes Unit, NCCAM, NIH, 10 Center Dr, Building 10, Room 6C-205, Bethesda, MD 20892-1632. E-mail quonm{at}nih.gov
Endothelial dysfunction contributes to cardiovascular diseases, including hypertension, atherosclerosis, and coronary artery disease, which are also characterized by insulin resistance. Insulin resistance is a hallmark of metabolic disorders, including type 2 diabetes mellitus and obesity, which are also characterized by endothelial dysfunction. Metabolic actions of insulin to promote glucose disposal are augmented by vascular actions of insulin in endothelium to stimulate production of the vasodilator nitric oxide (NO). Indeed, NO-dependent increases in blood flow to skeletal muscle account for 25% to 40% of the increase in glucose uptake in response to insulin stimulation. Phosphatidylinositol 3-kinase–dependent insulin-signaling pathways in endothelium related to production of NO share striking similarities with metabolic pathways in skeletal muscle that promote glucose uptake. Other distinct nonmetabolic branches of insulin-signaling pathways regulate secretion of the vasoconstrictor endothelin-1 in endothelium. Metabolic insulin resistance is characterized by pathway-specific impairment in phosphatidylinositol 3-kinase–dependent signaling, which in endothelium may cause imbalance between production of NO and secretion of endothelin-1, leading to decreased blood flow, which worsens insulin resistance. Therapeutic interventions in animal models and human studies have demonstrated that improving endothelial function ameliorates insulin resistance, whereas improving insulin sensitivity ameliorates endothelial dysfunction. Taken together, cellular, physiological, clinical, and epidemiological studies strongly support a reciprocal relationship between endothelial dysfunction and insulin resistance that helps to link cardiovascular and metabolic diseases. In the present review, we discuss pathophysiological mechanisms, including inflammatory processes, that couple endothelial dysfunction with insulin resistance and emphasize important therapeutic implications.
Key Words: diabetes mellitus • endothelium • hypertension • insulin
This article has been cited by other articles:
 |
|
 |
|
  M. Laakso Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms: The Kelly West Award Lecture 2008 Diabetes Care, February 1, 2010; 33(2): 442 - 449. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Akhtar, P. G. Barash, and S. E. Inzucchi Scientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control Anesth. Analg., February 1, 2010; 110(2): 478 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taddei and A. Virdis Exogenous Ghrelin on Nitric Oxide-Endothelin 1 Imbalance in Metabolic Syndrome: Can We Kill 2 Birds With 1 Stone? Hypertension, November 1, 2009; 54(5): 960 - 961. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Gogg, U. Smith, and P.-A. Jansson Increased MAPK Activation and Impaired Insulin Signaling in Subcutaneous Microvascular Endothelial Cells in Type 2 Diabetes: The Role of Endothelin-1 Diabetes, October 1, 2009; 58(10): 2238 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu and M.-H. Zou Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction Circulation, September 29, 2009; 120(13): 1266 - 1286. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, J. Liu, L. A. Jahn, D. E. Fowler, and E. J. Barrett Infusing Lipid Raises Plasma Free Fatty Acids and Induces Insulin Resistance in Muscle Microvasculature J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3543 - 3549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Traish, F. Saad, R. J. Feeley, and A. Guay The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease J Androl, September 1, 2009; 30(5): 477 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Potenza, F. Addabbo, and M. Montagnani Vascular actions of insulin with implications for endothelial dysfunction Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E568 - E577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Potenza, S. Gagliardi, L. De Benedictis, A. Zigrino, E. Tiravanti, G. Colantuono, A. Federici, L. Lorusso, V. Benagiano, M. J. Quon, et al. Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E685 - E694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S Rallidis, J. Lekakis, A. Kolomvotsou, A. Zampelas, G. Vamvakou, S. Efstathiou, G. Dimitriadis, S. A Raptis, and D. T Kremastinos Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity Am. J. Clinical Nutrition, August 1, 2009; 90(2): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, E. J. Barrett, S.-H. Ko, W. Cao, and Z. Liu Insulin and Insulin-Like Growth Factor-I Receptors Differentially Mediate Insulin-Stimulated Adhesion Molecule Production by Endothelial Cells Endocrinology, August 1, 2009; 150(8): 3475 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Song, N. R. Cook, C. M. Albert, M. Van Denburgh, and J. E. Manson Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women: A Randomized, Controlled Trial Diabetes, August 1, 2009; 58(8): 1921 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Song, M. Zhang, S. Wang, J. Xu, H. C. Choi, and M.-H. Zou Thromboxane A2 Receptor Activates a Rho-associated Kinase/LKB1/PTEN Pathway to Attenuate Endothelium Insulin Signaling J. Biol. Chem., June 19, 2009; 284(25): 17120 - 17128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lavi, A. Karasik, N. Koren-Morag, H. Kanety, M. S. Feinberg, and M. Shechter The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects. J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2283 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, Y. Huang, K. S.L. Lam, Y. Li, W. T. Wong, H. Ye, C.-W. Lau, P. M. Vanhoutte, and A. Xu Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovasc Res, June 1, 2009; 82(3): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Symons, S. L. McMillin, C. Riehle, J. Tanner, M. Palionyte, E. Hillas, D. Jones, R. C. Cooksey, M. J. Birnbaum, D. A. McClain, et al. Contribution of Insulin and Akt1 Signaling to Endothelial Nitric Oxide Synthase in the Regulation of Endothelial Function and Blood Pressure Circ. Res., May 8, 2009; 104(9): 1085 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Huang A comprehensive definition for metabolic syndrome Dis. Model. Mech., May 1, 2009; 2(5-6): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cirillo, Y. Y. Sautin, J. Kanellis, D.-H. Kang, L. Gesualdo, T. Nakagawa, and R. J. Johnson Systemic inflammation, metabolic syndrome and progressive renal disease Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1384 - 1387. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Park, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor {gamma} Transcription J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 571 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, K. Ishida, N. Nakayama, T. Kobayashi, and K. Kamata Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1388 - H1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Zhou, I. H. Schulman, and L. Raij Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H833 - H839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Koh, P. C. Oh, and M. J. Quon Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res, March 1, 2009; 81(4): 649 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Schelbert Coronary circulatory function abnormalities in insulin resistance insights from positron emission tomography. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S3 - S8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nacci, M. Tarquinio, L. De Benedictis, A. Mauro, A. Zigrino, M. R. Carratu, M. J. Quon, and M. Montagnani Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature Endocrinology, February 1, 2009; 150(2): 849 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species Physiol Rev, January 1, 2009; 89(1): 27 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Muniyappa, G. Hall, T. L Kolodziej, R. J Karne, S. K Crandon, and M. J Quon Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1685 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Duncan, P. A. Crossey, S. Walker, N. Anilkumar, L. Poston, G. Douglas, V. A. Ezzat, S. B. Wheatcroft, A. M. Shah, and M. I. Kearney Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo Diabetes, December 1, 2008; 57(12): 3307 - 3314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Huang and N. Sheibani High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1647 - C1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M Title, E. Lonn, F. Charbonneau, M. Fung, K. J Mather, S. Verma, and T. J Anderson Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome Vascular Medicine, November 1, 2008; 13(4): 263 - 270. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Kim, M. Pham, E. Maloney, N. O. Rizzo, G. J. Morton, B. E. Wisse, E. A. Kirk, A. Chait, and M. W. Schwartz Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin Resistance Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1982 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, A. S. Lin, Y. Li, C. E. N. Reiter, M. R. Ver, and M. J. Quon Dehydroepiandrosterone Stimulates Phosphorylation of FoxO1 in Vascular Endothelial Cells via Phosphatidylinositol 3-Kinase- and Protein Kinase A-dependent Signaling Pathways to Regulate ET-1 Synthesis and Secretion J. Biol. Chem., October 24, 2008; 283(43): 29228 - 29238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Laaksonen, L. Niskanen, K. Nyyssonen, T. A. Lakka, J. A. Laukkanen, and J. T. Salonen Dyslipidaemia as a predictor of hypertension in middle-aged men Eur. Heart J., October 2, 2008; 29(20): 2561 - 2568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jensterle, M. Sebestjen, A. Janez, J. Prezelj, T. Kocjan, I. Keber, and M. Pfeifer Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome Eur. J. Endocrinol., October 1, 2008; 159(4): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D'Aiuto, W. Sabbah, G. Netuveli, N. Donos, A. D. Hingorani, J. Deanfield, and G. Tsakos Association of the Metabolic Syndrome with Severe Periodontitis in a Large U.S. Population-Based Survey J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3989 - 3994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Goodwill, M. E. James, and J. C. Frisbee Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1522 - H1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Grassi, G. Desideri, S. Necozione, C. Lippi, R. Casale, G. Properzi, J. B. Blumberg, and C. Ferri Blood Pressure Is Reduced and Insulin Sensitivity Increased in Glucose-Intolerant, Hypertensive Subjects after 15 Days of Consuming High-Polyphenol Dark Chocolate J. Nutr., September 1, 2008; 138(9): 1671 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Davis, M. Jenab, J. P. Vanden Heuvel, T. Furlong, and S. Taylor Tree Nut and Peanut Consumption in Relation to Chronic and Metabolic Diseases Including Allergy J. Nutr., September 1, 2008; 138(9): 1757S - 1762S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kawakami, M. Osaka, M. Tani, H. Azuma, F. M. Sacks, K. Shimokado, and M. Yoshida Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction Circulation, August 12, 2008; 118(7): 731 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Moro, C. Pedone, S. Scarlata, V. Malafarina, F. Fimognari, and R. Antonelli-Incalzi Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease Angiology, July 1, 2008; 59(3): 357 - 364. [Abstract] [PDF]
|
|
|
|
|
|
F. Andreozzi, G. Formoso, S. Prudente, M. L. Hribal, A. Pandolfi, E. Bellacchio, S. Di Silvestre, V. Trischitta, A. Consoli, and G. Sesti TRIB3 R84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Koh, S. M. Park, and M. J. Quon Leptin and Cardiovascular Disease: Response to Therapeutic Interventions Circulation, June 24, 2008; 117(25): 3238 - 3249. [Full Text] [PDF]
|
|
|
|
|
|
L. M Ritland, D L. Alekel, O. A Matvienko, K. B Hanson, J. W Stewart, L. N Hanson, M. B Reddy, M. D Van Loan, and U. Genschel Centrally located body fat is related to appetitive hormones in healthy postmenopausal women. Eur. J. Endocrinol., June 1, 2008; 158(6): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, J.-P. del Rincon, L. A. Jahn, Y. Wu, B. Gaylinn, M. O. Thorner, and Z. Liu Growth Hormone Exerts Acute Vascular Effects Independent of Systemic or Muscle Insulin-like Growth Factor I J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1379 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-a Kim, Y. Wei, and J. R. Sowers Role of Mitochondrial Dysfunction in Insulin Resistance Circ. Res., February 29, 2008; 102(4): 401 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Consoli, E. Martelli, M. D'Adamo, R. Menghini, D. Arcelli, O. Porzio, A. Pandolfi, G. R. Pistolese, A. Consoli, R. Lauro, et al. Insulin Resistance Affects Gene Expression in Endothelium Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): e7 - e9. [Full Text] [PDF]
|
|
|
|
|
|
L. G. Mellbin, K. Malmberg, A. Norhammar, H. Wedel, L. Ryden, and for the DIGAMI 2 Investigators The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial Eur. Heart J., January 2, 2008; 29(2): 166 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. White, T. Guerin, H. Swanson, S. Post, H. Zhu, M. Gong, J. Liu, W. V. Everson, X.-A. Li, G. A. Graf, et al. Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin Am J Physiol Cell Physiol, January 1, 2008; 294(1): C295 - C305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Steiner Atherosclerosis in type 2 diabetes: a role for fibrate therapy? Diabetes and Vascular Disease Research, December 1, 2007; 4(4): 368 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Blouet, F. Mariotti, V. Mathe, D. Tome, and J.-F. Huneau Nitric Oxide Bioavailability and Not Production Is First Altered During the Onset of Insulin Resistance in Sucrose-Fed Rats Exp Biol Med, December 1, 2007; 232(11): 1458 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu Insulin at physiological concentrations increases microvascular perfusion in human myocardium Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1250 - E1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-G. Joost and M. H. Tschop NO to Obesity: Does Nitric Oxide Regulate Fat Oxidation and Insulin Sensitivity? Endocrinology, October 1, 2007; 148(10): 4545 - 4547. [Full Text] [PDF]
|
|
|
|
 |
|
 N. F Wiernsperger Review: 50 years later: is metformin a vascular drug with antidiabetic properties? The British Journal of Diabetes & Vascular Disease, September 1, 2007; 7(5): 204 - 210. [Abstract] [PDF]
|
|
|
|
|
|
H. Su, X. Sun, H. Ma, H.-F. Zhang, Q.-J. Yu, C. Huang, X.-M. Wang, R.-H. Luan, G.-L. Jia, H.-C. Wang, et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E629 - E635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Wolpin, D. S. Michaud, E. L. Giovannucci, E. S. Schernhammer, M. J. Stampfer, J. E. Manson, B. B. Cochrane, T. E. Rohan, J. Ma, M. N. Pollak, et al. Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer Cancer Res., August 15, 2007; 67(16): 7923 - 7928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Jonk, A. J. H. M. Houben, R. T. de Jongh, E. H. Serne, N. C. Schaper, and C. D. A. Stehouwer Microvascular Dysfunction in Obesity: A Potential Mechanism in the Pathogenesis of Obesity-Associated Insulin Resistance and Hypertension Physiology, August 1, 2007; 22(4): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Yegen, D. J. Lederer, R. G. Barr, J. S. Wilt, Y. Fang, E. Bagiella, F. D'Ovidio, J. M. Okun, J. R. Sonett, S. M. Arcasoy, et al. Risk Factors for Venous Thromboembolism After Lung Transplantation Chest, August 1, 2007; 132(2): 547 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Li, E. J. Barrett, M. O. Barrett, W. Cao, and Z. Liu Tumor Necrosis Factor-{alpha} Induces Insulin Resistance in Endothelial Cells via a p38 Mitogen-Activated Protein Kinase-Dependent Pathway Endocrinology, July 1, 2007; 148(7): 3356 - 3363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. Schulman, M.-S. Zhou, E. A. Jaimes, and L. Raij Dissociation between metabolic and vascular insulin resistance in aging Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H853 - H859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Serne, R. T. de Jongh, E. C. Eringa, R. G. IJzerman, and C. D.A. Stehouwer Microvascular Dysfunction: A Potential Pathophysiological Role in the Metabolic Syndrome Hypertension, July 1, 2007; 50(1): 204 - 211. [Full Text] [PDF]
|
|
|
|
|
|
K. K. Koh, M. J. Quon, Y. Lee, S. H. Han, J. Y. Ahn, W.-J. Chung, J.-a Kim, and E. K. Shin Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients Eur. Heart J., June 2, 2007; 28(12): 1440 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Hartge, T. Unger, and U. Kintscher The endothelium and vascular inflammation in diabetes Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 84 - 88. [Abstract] [PDF]
|
|
|
|
|
|
S. J Hamilton, G. T Chew, and G. F Watts Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 89 - 102. [Abstract] [PDF]
|
|
|
|
|
|
R. M Cubbon, A. Rajwani, and S. B Wheatcroft The impact of insulin resistance on endothelial function, progenitor cells and repair Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 103 - 111. [Abstract] [PDF]
|
|
|
|
|
|
K. K. Koh, M. J. Quon, S. J. Lee, S. H. Han, J. Y. Ahn, J.-a Kim, W.-J. Chung, Y. Lee, and E. K. Shin Efonidipine Simultaneously Improves Blood Pressure, Endothelial Function, and Metabolic Parameters in Nondiabetic Patients With Hypertension Diabetes Care, June 1, 2007; 30(6): 1605 - 1607. [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Zhong, X.-Y. Yu, Y. Huang, L.-M. Yung, C.-W. Lau, and S.-G. Lin Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice Cardiovasc Res, June 1, 2007; 74(3): 388 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-a Kim, G. Formoso, Y. Li, M. A. Potenza, F. L. Marasciulo, M. Montagnani, and M. J. Quon Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn J. Biol. Chem., May 4, 2007; 282(18): 13736 - 13745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Beckman, A. B. Goldfine, A. Dunaif, M. Gerhard-Herman, and M. A. Creager Endothelial Function Varies According to Insulin Resistance Disease Type Diabetes Care, May 1, 2007; 30(5): 1226 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K.Y. Cheng, K. S.L. Lam, Y. Wang, Y. Huang, D. Carling, D. Wu, C. Wong, and A. Xu Adiponectin-Induced Endothelial Nitric Oxide Synthase Activation and Nitric Oxide Production Are Mediated by APPL1 in Endothelial Cells Diabetes, May 1, 2007; 56(5): 1387 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Potenza, F. L. Marasciulo, M. Tarquinio, E. Tiravanti, G. Colantuono, A. Federici, J.-a Kim, M. J. Quon, and M. Montagnani EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1378 - E1387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Focardi, G. M. Dick, A. Picchi, C. Zhang, and W. M. Chilian Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2093 - H2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Viswambharan, J. M. Carvas, V. Antic, A. Marecic, C. Jud, C. E. Zaugg, X.-F. Ming, J.-P. Montani, U. Albrecht, and Z. Yang Mutation of the Circadian Clock Gene Per2 Alters Vascular Endothelial Function Circulation, April 24, 2007; 115(16): 2188 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lee, C. Shirodaria, C. E Jackson, M. D Robson, C. Antoniades, J. M Francis, F. Wiesmann, K. M Channon, S. Neubauer, and R. P Choudhury Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus Diabetes and Vascular Disease Research, March 1, 2007; 4(1): 44 - 48. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Potenza, F. L. Marasciulo, M. Tarquinio, M. J. Quon, and M. Montagnani Treatment of Spontaneously Hypertensive Rats With Rosiglitazone and/or Enalapril Restores Balance Between Vasodilator and Vasoconstrictor Actions of Insulin With Simultaneous Improvement in Hypertension and Insulin Resistance Diabetes, December 1, 2006; 55(12): 3594 - 3603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Oda Criteria for diagnosing the metabolic syndrome. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1251 - 1252. [Full Text] [PDF]
|
|
|
|
|
|
R. Muniyappa, R. J. Karne, G. Hall, S. K. Crandon, J. A. Bronstein, M. R. Ver, G. L. Hortin, and M. J. Quon Oral Glucosamine for 6 Weeks at Standard Doses Does Not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects Diabetes, November 1, 2006; 55(11): 3142 - 3150. [Abstract] [Full Text] [PDF]
|
|